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Objective: Radionuclide imaging with fluorodeoxyglucose (FDG) and positron emission tomography (PET) has been
proposed for the identification of vascular graft infection; however, its accuracy has not been determined. We performed
this prospective study to compare the usefulness of FDG-PET in the assessment of vascular graft infection relative to
computed tomography (CT).
Methods: FDG-PET was performed for 33 consecutive patients with a suspected arterial prosthetic graft infection. The
PET images were then assessed visually in terms of the density of uptake. In cases with positive uptake, the pattern of
accumulation was also defined, such as focal or diffuse uptake. We compared the diagnostic efficiency of PET with
contemporaneous CT in detection of infection of the arterial prosthetic graft.
Results: On the basis of the surgical, microbiological, and clinical follow-up findings, the aortic grafts were considered
infected in 11 patients and not infected in 22 patients. Although the sensitivity of PET (91%) was higher than that of CT
(64%), its specificity (64%) was lower than that of CT (86%). When focal uptake was set as the positive criterion in FDG,
the specificity and positive predictive value of PET for the diagnosis of aortic graft infection improved significantly to 95%
(P < .05 for both).
Conclusions: Although both techniques are useful in evaluation of patients with suspected aortic graft infection, using the
characteristic FDG uptake pattern described previously as a diagnostic criterion made the efficacy of FDG superior to that
of CT in the diagnostic assessment of patients with suspected aortic graft infection. (J Vasc Surg 2005;42:919-25.)Aortic prosthetic graft infection is associated with high
morbidity and mortality in the absence of immediate, de-
finitive antibiotic therapy and surgical intervention.1 Com-
puted tomography (CT) has been used as a complementary
imaging approach for the assessment of graft infection,
because the high spatial resolution of CT provides exquisite
detail of the vascular structure and perivascular spaces.
However, hematomas and seromas in the vicinity of a
vascular graft appear anatomically similar to an abscess, thus
making it sometimes difficult to distinguish between non-
infected and infected prosthetic grafts on CT images.2
Thus, a reliable physiological approach is required to eval-
uate the inflammatory activity, to detect infected prosthe-
ses, and to determine the extent of infection, in addition to
anatomic information.
Investigators have recently suggested that fluorodeoxy-
glucose (FDG) positron emission tomography (PET) im-
aging may be useful for detection of infection3,4 and eval-
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doi:10.1016/j.jvs.2005.07.038uation of infected vascular grafts.5-7 However, because the
vascular graft regions can exhibit a substantial inflammatory
reaction that results in some FDG accumulation,8 the value
of FDG-PET in the assessment of vascular graft infection is
still ambiguous. We hypothesized that PET, because of its
ability to detect inflammation, would be a more sensitive
and specific test for aortic graft infection. To clarify this
issue, we conducted this preliminary study to examine the
feasibility of using FDG-PET for the diagnosis of aortic
graft infection in comparison with CT.
METHODS
Patient recruitment. This study was a prospective anal-
ysis of consecutive patients undergoing combined FDG-PET
and CT between September 2002 and November 2004 in
National Cardiovascular Center Hospital. Thirty-three pa-
tients whounderwent aortic reconstructive surgerywith graft-
ing for the treatment of aortic aneurysm, aortic dissection, or
aortoiliac occlusive disease (mean age, 71 14 years [mean
 SD]; age range, 22-83 years) were enrolled in the study.
These patients were categorized into three groups accord-
ing to the criteria of Fiorani et al.9 Nine patients had
suspected advanced aortic graft infection with manifesta-
tions of severe infection, 17 had suspected low-grade aortic
graft infection with nonspecific manifestations of infection,
and 7 were asymptomatic control patients selected from a
review of patients at our institution who had undergone
FDG whole-body PET mainly for oncologic purposes dur-
919
ction;
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surgical and microbiological findings. In cases in which no
surgical treatment or no microbiologic samples were avail-
able, clinical follow-up for more than 4 months served as
the standard reference. Twenty-five patients had received
some antibiotic therapy before the FDG-PET and CT
study, but the drugs were not changed until after both
imaging studies. Patients with diabetes mellitus were ex-
cluded from the study because this condition can affect the
FDG uptake.10 This study was conducted with the approval
of our institutional review board, and we obtained written
informed consent from all the subjects before their partic-
ipation in the study.
CT protocol. CT scanning was conducted within 1
week before FDG-PET by using a helical or multidetector
CT system (Aquilion; Toshiba Medical Co, Tochigi, Ja-
pan). Contiguous 1-cm sections were obtained at 1-cm
intervals from the lung apices to the inguinal region after
bolus intravenous injection of contrast material, except in
Table I. Patient characteristics
Patient
No. Age/sex
Primary
disease
Type of
operation
1 75/M AAA Y-graft
2 74/M TAA TAR
3 80/M AAA I-F bypass
4 62/M TAA TAR
5 78/M AAA Y-graft
6 83/F IA TAR
7 83/M AAA Y-graft
8 74/M TAA TAR
9 22/M AE Ascending graft
10 31/M AD TAR
11 80/M TAA TAR
12 75/M IA S-graft
13 70/M AAA Y-graft
14 77/F AAA Y-graft
15 77/M AAA Y-graft
16 75/M AAA A-F bypass
17 64/M AAA Y-graft
18 82/F AAA S-graft
19 83/M TAA TAR
20 73/M AAA Y-graft
21 63/M AAA Y-graft
22 66/M AAA Y-graft
23 72/M AAA Y-graft
24 76/M AAA Y-graft
25 75/M AAA Y-graft
26 68/F AAA A-F bypass
27 80/M AAA Y-graft
28 76/M AAA Y-graft
29 83/M TAA Descending gra
30 75/M AD Descending gra
31 49/M TAA Descending gra
32 82/M TAA TAR
33 72/M TAA Descending gra
CT,Computed tomography; PET, positron emission tomography;AAA, abd
TAA, thoracic aortic aneurysm; TAR, total arch replacement; MF, microb
ectasia;AD, aortic dissection; S-graft, straight graft;NEI, no evidence of infe
positive.four patients with acute or chronic renal failure.PET protocol. Patients were instructed to fast for at
least 5 hours before FDG-PET studies. Transmission
scans were initially obtained by using a line source of
germanium 68/gallium 68, and then 185 MBq of FDG
was administered intravenously. One hour later, emis-
sion from the entire body was imaged for 25 minutes; at
least five bed positions were used. The emission data
obtained from the ECAT EXACT 47 (Siemens/CTI,
Knoxville, Tenn) were consecutively reconstructed with
measured attenuation correction based on the transmis-
sion data.
Image interpretation. All the CT scans were re-
viewed independently by two of the authors, who had no
knowledge of the clinical or operative findings. In accor-
dance with a previously described method,11 each CT
scan was assessed for the presence of ectopic gas, peri-
graft fluid (20 Hounsfield Units), perigraft soft tissue
(20 Hounsfield Units), pseudoaneurysm formation,
discontinuity of the aneurysmal wrap, and an increased
Final
diagnosis
Proof of
infection
CT
findings
PET
findings
Infection ST TP TP
Infection MF FN TP
Infection ST TP TP
Infection ST FN TP
Infection ST TP TP
Infection ST FN TP
Infection MF TP TP
Infection MF FN TP
Infection MF TP TP
Infection CF FN TP
Infection CF TP TP
NEI CF TN TN
NEI AsC TN FP
NEI AsC TN TN
NEI CF TN TN
NEI CF TN TN
NEI ST FP TN
NEI AsC TN TN
NEI ST FP TN
NEI CF TN TN
NEI AsC TN FP
NEI CF TN TN
NEI CF TN FP
NEI AsC TN FP
NEI CF FP TN
NEI AsC TN FP
NEI ST TN TN
NEI CF TN FP
NEI CF TN TN
NEI CF TN TN
NEI ST TN TN
NEI AsC TN FP
NEI CF TN FP
al aortic aneurysm; I-F, iliofemoral; ST, surgical treatment; TP, true positive;
ical findings; FN, false negative; IA, infected aneurysm; AE, annuloaortic
TN, true negative;CF, clinical feature;AsC, asymptomatic controls; FP, falseft
ft
ft
ft
omin
iologamount of soft tissue (5 mm) between the graft and the
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the observers disagreed, a consensus of the two observers
was obtained.
The FDG-PET images were analyzed by two indepen-
dent experienced physicians who specialized in nuclear
medicine and who were blinded to the results of the other
imaging studies. They used the same image-evaluation
criteria as those used in a previous FDG-PET study for
detection of orthopedic infection.12 The intensity of FDG
uptake was graded on a five-point scale, as follows: grade 0,
FDG uptake similar to that in the background; grade 1, low
FDGuptake, comparable to that by inactivemuscles and fat;
grade 2, moderate FDG uptake, clearly visible and dis-
tinctly higher than the uptake by inactive muscles and fat;
grade 3, strong FDG uptake, but distinctly less than the
physiologic uptake by the bladder; and grade 4, very strong
FDG uptake, comparable to the physiologic urinary uptake
by the bladder. In a previous investigation by Stumpe
et al,12 the results of a receiver operating characteristic
analysis had shown that classifying lesions with grade 3 or 4
uptake as infected lesions yielded the best discrimination
between infected and noninfected lesions. Therefore, in-
creased grade 3 or 4 FDGuptake by a prosthesis was used as
the diagnostic criterion for infection in our study. In addi-
tion, in cases showing abnormal FDG uptake, the readers
also described the pattern of abnormal uptake, namely,
whether it was focal or diffuse. An abnormality was inter-
preted as diffuse if it was located along the prosthesis
consecutively. An abnormality was called focal if it was
located in a region other than along the prosthesis and was
dotted in configuration.
Statistical analysis. Data are expressed as means 
SD. The interobserver agreement of image interpretation
was estimated by using the  statistic.13 Concordance was
considered to be good for  values more than 0.6, moder-
ate for values from 0.6 to 0.4, and poor for values less than
0.4.14 Comparisons between groups were conducted by
using the unpaired t test for continuous variables. The
diagnostic performance was expressed in terms of the sensitiv-
ity, specificity, accuracy, positive predictive value (PPV), and
Table II. Demographic data of patients with
and without aortic graft infection
Variable
Group
P valueWith infection Without infection
Age (y) 68  21 73  8 NS
Sex (F/M) 1/10 3/19 NS
Smoking 7/11 (64%) 15/22 (68%) NS
CRP (mg/dL) 5.6  5.0 3.5  4.5 NS
FBS (mg/dL) 100  10 97  14 NS
Duration (mo) 11.8  9.4 12.5  9.2 NS
Location of graft
(thorax/abdomen) 7/4 6/16 .04
Data are n (%) or mean  SD.
CRP, C-reactive protein; FBS, fasting blood sugar; NS, not significant.negative predictive value (NPV), with 95% confidence in-tervals. Differences in the diagnostic performance between
the two imaging modalities and criteria were considered
significant when the 95% confidence intervals did not over-
lap.15
RESULTS
The characteristics of patients and the results of imag-
ing are presented in Table I. Eleven of 33 patients were
definitively categorized as having infected grafts on the
basis of the surgical procedure, including graft removal,
aortic ligation, and extra-anatomic bypass grafting (n 5),
and microbiological findings, including blood culture and
follow-up imaging studies (n  6). Another 22 patients
were definitively categorized in the noninfected-graft
group. There were no significant differences between the
two groups in the patients’ mean age, sex distribution,
Fig 1. Example of true-positive findings on computed tomogra-
phy (CT) and fluorodeoxyglucose (FDG) positron emission to-
mography in a patient with graft infection. The patient had under-
gone total aortic arch replacement 4 months before the imaging
examinations. Focal FDG accumulation in the graft (black arrows)
is accompanied by fluid collection and extraluminal air on the
enhanced CT image (white arrows).history of smoking, serum C-reactive protein, or blood
JOURNAL OF VASCULAR SURGERY
November 2005922 Fukuchi et alsugar at the time of the PET study or during follow-up after
surgery. However, the incidence of infection in thoracic
aortic grafts was significantly higher than that in abdominal
grafts (Table II).
Regarding the interpretation of CT images, the inter-
observer agreement on positive observations was 0.85, and
the  value was 0.67. CT revealed true-positive findings in
7 cases and false-positive findings in 3, and it showed a
true-negative result in 19 and a false-negative result in 4.
All FDG-PET images were considered appropriate for
interpretation. Interobserver agreement on positive obser-
vations was 0.82, and the  value was 0.61. FDG-PET
showed true-positive findings in 10 cases and false-positive
findings in 8, and it showed a true-negative result in 14 and
a false-negative result in one. All patients with true-positive
findings on CT also showed increased FDG uptake by the
corresponding lesions (Fig 1). Additionally, in all cases with
false-negative CT findings, FDG-PET could depict the
Fig 2. Example of a false-negative computed tomography (CT)
result and true-positive fluorodeoxyglucose (FDG) positron emis-
sion tomography (PET) findings in a patient with graft infection.
The patient had undergone total aortic arch replacement 4 months
before the imaging examinations. Focal FDG accumulation in the
ascending aortic graft (black arrow) is seen in the FDG-PET
image, but only soft tissue swelling is seen in the plain CT image
(white arrow). Physiological FDG accumulation was also seen at
the site of sternotomy (arrowhead).lesions as positive (Fig 2). Only one patient with false-positive CT findings underwent reoperative irrigation, and
the preoperative FDG-PET result in that patient was com-
pletely negative (Fig 3). Histopathologic assessment of the
resected specimen also confirmed that the perigraft mass
represented noninfected sterile fluid in that case. FDG-PET
showed positive findings of infection, based on the visual
assessment criteria, in eight patients without graft infection.
In these patients with false-positive FDG findings, the FDG
uptake grade differed, but the pattern of uptake was diffuse
and circumferential around the prosthetic graft in all cases
(Fig 4).
On the basis of these data, the sensitivity, specificity,
PPV, NPV, and accuracy of CT for the diagnosis of graft
infection were 64%, 86%, 70%, 83%, and 79%, respectively.
The corresponding values for FDG-PET were 91%, 64%,
56%, 93%, and 73%, respectively. The sensitivity of FDG-
PET (91%) was significantly higher than that of CT (64%; P
 .05); however, the specificity of FDG-PET (64%) was
lower than that of CT (86%; not significant). When the
PET criterion for infection was defined as focal abnormal
Fig 3. Example of false-positive findings on computed tomogra-
phy (CT) and a true-negative result on fluorodeoxyglucose (FDG)
positron emission tomography in a patient without graft infection.
An exophytic perigraft fluid density is seen (white arrows) at the
prosthetic aortic arch on a contrast-enhanced CT image. At this
site, there is no accumulation of FDG at all (black arrows).uptake with respect to the characteristics of false-positive
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negative. With this alteration of the diagnostic criteria, the
specificity and PPV of FDG-PET improved significantly
from 64% to 95% and 56% from 91%, respectively (P .05).
An overview of the diagnostic performance of CT and of
FDG using the two methods of assessment, as well as the
95% confidence intervals, is shown in Table III.
DISCUSSION
Because infection of aortic prosthetic grafts remains a
major surgical challenge, it is essential for aortic graft
infection to be diagnosed accurately and safely.1,2 CT and
scintigraphic techniques are currently the most commonly
used modalities for diagnosis of aortic graft infection.2
Because of the rapidity with which it can be performed, CT
should be the first examination ordered in cases of sus-
pected aortic graft infection. Studies of the early 1980s have
showed specificity and sensitivity of CT of approximately
100%.16 However, studies of the late 1980s, which in-
Fig 4. Example of a true-negative computed tomography (CT)
result and false-positive fluorodeoxyglucose positron emission to-
mography (FDG-PET) findings in a patient without graft infec-
tion. The prosthetic aortic graft can be seen as a high-density rim
around the ascending aortic region on CT (white arrows). The
FDG-PET image depicts a relatively dense and diffuse uptake
around the graft (black arrows).cluded cases with low-grade infection, indicated an overalldiagnostic sensitivity of 55.5% and an overall diagnostic
specificity of 100% of CT for graft infection.9 This imaging
modality was considered an accurate method for diagnosis
of advanced graft infection (periprosthetic abscess, aor-
toenteric fistula, and so on), but the risk of false-negative
results is high in cases with low-grade graft infection. In this
study, CT failed to identify three cases with aortic graft
infection; consequently, the sensitivity of CT for the diag-
nosis of aortic graft infection decreased to 64%. Thus, it
would be desirable to identify another imaging modality,
besides CT, with a high sensitivity for detecting aortic graft
infection.
Whereas CT affords visualization of the structural
changes secondary to infection, nuclear medicine tech-
niques allow such infections to be diagnosed on the basis of
molecular biological changes.2 Although several types of
scintigraphic techniques have been used for many years,
FDG-PET has drawnmuch attention recently for diagnosis
of infectious diseases. Previous articles have shown that
FDG-PET can be a very sensitive imaging modality for
diagnosis of infection,3,4 because increased FDG uptake is
observed in the activated inflammatory cells, such as leuko-
cytes, granulocytes, and macrophages.17 Although some
case reports have been published,5-7 the usefulness of FDG-
PET in the diagnosis of aortic graft infection has not yet
been evaluated on sufficiently large numbers of patients.
This study confirmed the feasibility of FDG-PET for
detecting aortic graft infection. As compared with the
conventional nuclear medicine techniques, PET is consid-
ered to have the following advantages.4 First, the PET
procedure is much faster than the conventional modalities,
and its results can usually be made available within 2 hours.
Second, the better spatial resolution of the PET system as
compared with that of a gamma camera results in a higher
diagnostic sensitivity. Third, PET generally provides higher-
quality images with superior contrast compared with single
photon emission CT. Thus, FDG-PET can be used to
assess the extent of infection more sensitively and can
quantify the inflammatory activity more accurately than a
gamma camera. The superiority of FDG-PET compared
with other gamma camera techniques has been confirmed
in oncology, but not yet in infectious disease.18,19 Unfor-
tunately, we could not compare FDG-PET with the con-
ventional gamma camera imaging modalities in this study,
but the above-mentioned advantages suggest that FDG-
PET has the possibility to replace them as a diagnostic tool
for patients with suspected aortic graft infection.
Although the ability of FDG-PET to diagnose several
types of infection with a high sensitivity has been encour-
aging, high sensitivity inevitably means a certain number of
false-positive results.4 Previous reports indicated that pros-
thetic vascular graft replacement was sometimes associated
with a false-positive FDG uptake in the graft or stent
regions.8,20 Our visual FDG-PET analysis also showed a
false-positive accumulation in 8 (36%) of 22 patients with
noninfected grafts. This false-positive accumulation might
be explained as FDG uptake during the process of normal
foreign body reaction or inflammation during the normal
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Other scintigraphic studies, including white blood cell or
leukocyte scans, also showed a certain number of false-
positive results.21,22 This inevitable reaction might confound
the critical diagnosis of aortic graft infection. However, these
normal inflammatory reactions might be distinguished from
infection by using the characteristic uptake patterns of FDG
as diagnostic criteria, because nonspecific inflammation was
associated with diffuse uptake along the prosthetic graft,
whereas true infection was associated with focal or segmen-
tal FDG uptake, mostly at sites of abnormal CT findings. In
this study, eight cases showed various degrees of false-
positive FDG uptake, but the pattern of uptake was diffuse
along the prosthetic graft in all cases. This feature can be a
useful marker for differentiating between infected and non-
infected aortic grafts. In fact, using focal uptake as a diag-
nostic criterion resulted in a statistically significant increase
in the specificity and PPV of FDG-PET for the diagnosis of
graft infection as compared with that of the conventional
visual assessment. Using this focal sign may not always be
versatile, because some grafts are entirely infected. In this
type of infection, the focal findings do not work and cause
misdiagnosis. We emphasize that the use of a combination
of intensity and pattern of FDG uptake with reference to
the information of CT scans may allow one to clearly
distinguish between infected and noninfected aortic grafts.
More extensive clinical evaluation is warranted to deter-
mine the accuracy of this method.
Recently, a fusion technology between FDG-PET and
CT, acquired in a single session, has been developed that
enables precise localization of any abnormal FDG up-
take.23,24 This hybrid PET/CT method is expected to
become increasingly popular in the field of nuclear medi-
cine, because FDG-PET always requires anatomic informa-
tion for accurate localization of any abnormal tracer distri-
bution. We could not use PET/CT in our present study,
but a few case reports have confirmed the feasibility of
PET/CT for the diagnosis of vascular prosthesis infec-
tion.5,7 An incremental benefit of PET/CT over PET alone
can be expected, but further studies should be undertaken
to determine the role of FDG-PET/CT in the diagnosis of
Table III. Diagnostic performances of CT and FDG-PET
vascular grafts
Variable CT findings
Sensitivity 0.64 (0.48-0.80)
Specificity 0.86 (0.74-0.98)
Accuracy 0.79 (0.65-0.93)
PPV 0.70 (0.54-0.86)
NPV 0.83 (0.70-0.96)
Numbers in parentheses are 95% confidence intervals.
CT, Computed tomography; PET, positron emission tomography; PPV, po
*P  .05, FDG-PET vs CT for sensitivity.
†P  .05, FDG-PET (focal) vs FDG-PET (positive) for specificity.
‡P  .05, FDG-PET (focal) vs FDG-PET (positive) for PPV.vascular prosthesis infection.In this preliminary study, there were some limitations.
First, the inability to confirm infection in these patients
and, thus, have a gold standard is a fundamental problem in
our attempt to test the diagnostic performance of FDG-
PET. In cases in which no surgical treatment was available,
follow-up CT and FDG-PET examinations were per-
formed until the patient’s fever, C-reactive protein levels,
and positive blood cultures returned to the average level.
However, it remains unsolved whether true infection ex-
isted in cases with FDG-PET–positive but CT-negative
results in this study. Although vascular graft infection is rare
complication, further studies including a larger population
of precisely diagnosed graft infections are required. Second,
we excluded patients with diabetes mellitus because this
condition can affect the distribution of FDG uptake.10
Although extensively assessed in patients with malignan-
cies, the effect of hyperglycemia on FDG uptake by inflam-
matory and infectious processes is not well documented,
and the effect of increased glucose serum levels on PET
sensitivity is a controversial issue.25-27 Accordingly, we
tested the feasibility of FDG-PET in patients without dia-
betes mellitus. Recently, Keidar et al28 have tested the role
of FDG-PET/CT in the diagnosis of diabetic foot osteo-
myelitis. In their study, although increased serum glucose
values were found in half of the study population, this did
not lead to false-negative results. Because the large num-
bers of patients with vascular prosthesis have overt diabetes
mellitus, further studies should be carried out to determine
the feasibility of FDG in the diagnosis of vascular prosthesis
infection in such patients. Third, approximately 75% of the
patients had received antibiotics before CT and PET in this
study. It was anticipated that antibiotic therapy before PET
scanning would have some effect on the individual “false-
negative” findings. In our study, both PET and CT scans
might be equally influenced by antibiotics because medica-
tion started before and did not change throughout the
imaging studies. Thus, the comparison between the two
modalities is thought to be reliable. Fourth, PET is sub-
stantially more expensive than CT.29-31 We did not have
enough data to test the cost-effectiveness of FDG-PET for
infectious diseases because the use of PET in this clinical
differentiation between infected and noninfected
Visual assessment of FDG-PET
Positive/negative Focal/not
0.91 (0.81-1.00)* 0.91 (0.81-1.00)*
0.64 (0.48-0.80) 0.95 (0.88-1.02)†
0.73 (0.58-0.88) 0.94 (0.86-1.02)
0.56 (0.39-0.73) 0.91 (0.81-1.01)‡
0.93 (0.84-1.02) 0.95 (0.88-1.02)
predictive value; NPV, negative predictive value.for
sitivefield has just started. It would be expected that PET can
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costs when used appropriately in the management of pa-
tients with infected aortic grafts. To prove this, further
studies are necessary.
In conclusion, FDG-PET seems to be a promising
modality for the evaluation and management of infected
aortic grafts and may serve as a useful tool for noninvasive
diagnosis of this clinical problem. Moreover, FDG-PET
shows a diagnostic performance superior to that of CT
when specific uptake patterns of FDG are included in the
diagnostic criteria.
The authors thank Yoshinori Miyake, Hisashi Oka, and
Masayoshi Sagoh for their skillful technical support in
connection with the FDG studies.
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